Tirzepatide

( DrugBank: Tirzepatide / KEGG DRUG: Tirzepatide )


5 diseases
IDDisease name (Link within this page)Number of trials
67Polycystic kidney disease1
96Crohn disease3
97Ulcerative colitis2
IDDisease name (Link within this page)Number of trials
193Prader-Willi syndrome1
233Wolfram syndrome2

67. Polycystic kidney disease


Clinical trials : 233Drugs : 188 - (DrugBank : 54) / Drug target genes : 60 - Drug target pathways : 165 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

96. Crohn disease


Clinical trials : 2,737Drugs : 1,197 - (DrugBank : 240) / Drug target genes : 182 - Drug target pathways : 221 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

97. Ulcerative colitis


Clinical trials : 3,305Drugs : 1,646 - (DrugBank : 318) / Drug target genes : 165 - Drug target pathways : 220 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

193. Prader-Willi syndrome


Clinical trials : 128Drugs : 94 - (DrugBank : 25) / Drug target genes : 51 - Drug target pathways : 102 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

233. Wolfram syndrome


Clinical trials : 12Drugs : 14 - (DrugBank : 6) / Drug target genes : 3 - Drug target pathways : 6 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries